The protein expression of Bcl-2, Bax, Fas/Apo-1 in acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Tongji Medical University = Tong ji yi ke da xue xue bao

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/bf02888279PMID 10806802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bax mutations in cell lines derived from hematological malignancies.

  1995cited by this paper
• Switching recognition of two tRNA synthetases with an amino acid swap in a designed peptide.

  1995cited by this paper
• Overexpression of the Bcl-2 Protein Increases the Half-life of p21Bax(*)

  1995cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993cited by this paper
• Control of programmed cell death in normal and leukemic cells: new implications for therapy.

  1993cited by this paper

• C18H17NO6 and Its Combination with Scutellarin Suppress the Proliferation and Induce the Apoptosis of Human Glioma Cells via Upregulation of Fas-Associated Factor 1 Expression

  2019cites this paper
• Comparative analysis of the effects of sample source and test methodology on the assessment of protein expression in acute myelogenous leukemia

  2005cites this paper
• ×Phosphorylation of Bax Ser184 by Akt Regulates Its Activity and Apoptosis in Neutrophils*

  2004cites this paper